CTAS
Cintas
Data as of 2026-10-14
Company attributes
Price
Interactive 5-year price history chart for CTAS. Latest close $205.23.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency94ExceptionalIndustrials median (n=263) 50
- ValuePrice vs fundamentals11PoorIndustrials median (n=263) 50
- GrowthRevenue & earnings trajectory48AverageIndustrials median (n=263) 51
- MomentumRecent price strength71ExceptionalIndustrials median (n=263) 43
- HealthBalance sheet & solvency71ExceptionalIndustrials median (n=263) 58
- ProfitabilityROE, ROA, ROIC91ExceptionalIndustrials median (n=263) 50
- TechnicalTrend & volatility signals64StrongIndustrials median (n=263) 48
- RiskVolatility & drawdown profile72ExceptionalIndustrials median (n=263) 48
Pillars not shown: Sentiment, ML (Phase 5+).
Fair price check
6 different valuation methods each estimate what CTAS should be worth, then we compare to today's price.
- P/E multiplesOvervaluedthinks it's expensive — estimates $117.68, about 43% below today
- EV/EBITDAOvervaluedthinks it's expensive — estimates $99.61, about 51% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $50.92, about 75% below today
- P/B multiplesOutlierestimate looks unreliable — estimates $37.54 — likely unreliable
- Graham (defensive)Outlierestimate looks unreliable — estimates $25.18 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $10.99 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $44.23
- Margin of safety(vs fair value)
- < −99%
- Max (ex-outliers)
- $117.68
- Tangible BVPS
- $3.46
- Goodwill-heavy balance sheet
- Extreme Graham estimate
- Extreme P/B estimate
- Extreme Residual-Income estimate
- Majority of methods extreme
Median of all applicable methods (current price $205.23). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $81.49B |
| Revenue (TTM) | $11.56B |
| Net income (TTM) | $2.06B |
| Operating cash flow (TTM) | $2.43B |
| CapEx (TTM) | $400.68M |
| Free cash flow (TTM)CFO − CapEx | $2.03B |
| Total assets | $10.65B |
| Total liabilities | N/A |
| Stockholders' equity | $5.20B |
| Cash & equivalents | $243.60M |
| Shares outstanding | 397.08M |
| EPS (basic) | $5.19 |
| EPS (diluted) | $5.19 |
| P/E ratio (TTM) | 39.55 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-10-07
- Latest period end
- 2026-09-30
- Filing lag
- 7 days
- Missing metrics
- 2(total_liabilities, research_and_development)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.